NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)

The National Library of Medicine (NLM), part of the National Institutes of Health (NIH), is offering funding through the NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed). This grant supports the preparation of book-length manuscripts and other scholarly works with academic and public health policy significance for U.S. health professionals, public health officials, biomedical researchers, historians of health sciences, and scholars working at the intersection of digital humanities and data science. The goal of this funding opportunity is to allow researchers and scholars to dedicate significant time to producing comprehensive scholarly works that address critical gaps in the biomedical and health sciences fields. This grant supports various types of projects, including major critical reviews, state-of-the-art summaries, historical studies, and other organized presentations of knowledge in clinical medicine, public health, biomedical research, and information sciences. The grant will not support archival research, data collection, textbooks, online learning modules, journal articles, or works for lay audiences. Additionally, projects aimed at commercial viability or limited local interest are ineligible. All funded works must be published by a commercial or academic press, ensuring quality and broad dissemination. Eligible applicants include higher education institutions (both public and private), nonprofit organizations, state and local governments, special district governments, independent school districts, and federally recognized as well as non-recognized Native American tribal governments. Faith-based organizations, regional organizations, and public housing authorities are also eligible. Foreign institutions and non-domestic components of U.S. organizations are not eligible. Applicants must complete multiple registrations, including System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (for foreign organizations), Unique Entity Identifier (UEI), eRA Commons, and Grants.gov, prior to submission. The application period opens on January 26, 2024, with due dates on February 26, 2024; February 26, 2025; and February 26, 2026. The scientific merit review will occur in July of the respective years, followed by advisory council reviews in October, and awards will be issued in December. A letter of intent is encouraged but not required. Applicants must follow the NIH’s SF424 (R&R) Application Guide and provide details on the project's significance, innovation, and approach, along with supporting documents, such as a sample chapter and chapter outline. Funding is available for up to $75,000 per year in direct costs for salaries and fringe benefits of project personnel, with an additional $5,000 per year allowed for other costs, such as supplies, editing, or travel. The total project period is limited to two years. Facilities and administrative costs will be reimbursed at an organization's negotiated rate. The number of awards will depend on NIH appropriations and the number of qualified applications. No cost-sharing or matching funds are required. Applications will be reviewed for scientific merit by a peer review panel, considering factors such as the significance, approach, investigator qualifications, and innovation of the proposed work. Successful applicants will receive a Notice of Award from NIH, and grantees must submit two copies of their final published work to NLM. For additional information, applicants can contact program officials at NLM, including Dr. Sung Sug (Sarah) Yoon, Dr. Elizabeth Anne Barr, and Dr. Zoe Huang.